Evidence map›Paper›PMID 39639391›Full record

ArticleParasites & vectors2024

Monitoring alpha-cypermethrin susceptibility of Phlebotomus argentipes, the vector of visceral leishmaniasis in India, using the CDC bottle bioassay.

Rahul Chaubey, Ashish Shukla, Anurag Kumar Kushwaha, Shakti Kumar Singh, Om Prakash Singh, Rajiv Kumar, Phillip Lawyer, Edgar Rowton, Christine A Petersen, Scott A Bernhardt and 1 more

Abstract read
In one paragraph

Article in Parasites & vectors, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rahul Chaubey *Kala-Azar Medical Research Center (KAMRC), Muzaffarpur, Bihar, India.
Ashish Shukla *Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Anurag Kumar KushwahaDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Shakti Kumar SinghNational Museum of Natural History, Ministry of Environment Forest and Climate Change, New Delhi, India.
Om Prakash SinghDepartment of Biochemistry, Institute of Science, Banaras Hindu University, Varanasi, India.
Rajiv KumarCentre of Experimental Medicine & Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Phillip LawyerArthropod Collections, Monte L. Bean Life Science Museum, Brigham Young University, Provo, UT, USA.
Edgar RowtonDivision of Entomology, Walter Reed Army Institute of Research, Silver Spring, MD, USA.
Christine A PetersenDepartment of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
Scott A BernhardtDepartment of Biology, Utah State University, Logan, UT, USA. scott.bernhardt@usu.edu.
Shyam SundarKala-Azar Medical Research Center (KAMRC), Muzaffarpur, Bihar, India. drshyamsundar@hotmail.com.

Funding

Alteration of skin immune environment by sand fly saliva across progressive LeishmaniasisR01AI171971 · NIAID · UNIVERSITY OF IOWA · PI Christine A Petersen · 2022 to 2026
$3.0M
Visceral Leishmaniasis in Bihar State, IndiaU19AI074321 · NIAID · BANARAS HINDU UNIVERSITY · PI SUNDAR, SHYAM · 2017 to 2021
$2.8M
Epidemic modeling framework for complex, multi-species disease processesR01TW010500 · FIC · UNIVERSITY OF IOWA · PI OLESON, JACOB, PETERSEN, CHRISTINE A · 2016 to 2020
$2.4M
Banaras Hindu University Institute of Eminence (IoE) Seed and Incentive grantFIC NIH HHS R01 TW010500Indian Council of Medical Research ICMR DDR/IIRP-2023-3774 (P-14/0796)NIAID NIH HHS R01 AI171971NIAID NIH HHS U19 AI074321NIH HHS TMRC U19AI074321
6 · The paper itself

Abstract

backgroundVisceral leishmaniasis (VL), known as Kala-azar on the Indian subcontinent, is a parasitic disease caused by the flagellated protozoa Leishmania donovani and can be fatal if left untreated. The sand fly Phlebotomus argentipes is the only proven vector of VL in the Southeast Asia region, and VL control in this region has relied on the use of synthetic insecticides for indoor residual spraying (IRS). The use of DDT in VL control programmes has led to the development of resistance to this insecticide in sand flies, resulting in DDT being replaced with the insecticide alpha-cypermethrin. However, alpha-cypermethrin has a similar mode of action as DDT and, therefore, the risk of resistance development in sand flies increases under the pressure of regular exposure to this insecticide. In the present study we assessed the susceptibility status of wild-caught sand flies and F1 progeny using the CDC bottle bioassay.

methodsSand flies were collected from 10 villages in Muzaffarpur District, Bihar, India. Eight of these villages are receiving continuous IRS with alpha-cypermethrin, one village had discontinued IRS with alpha-cypermethrin and one village had never received IRS with alpha-cypermethrin. The collected sand flies were exposed to a pre-determined diagnostic dose for a specific time duration (3 µg/ml for 40 min), and knockdown and mortality at 24 h post-exposure were recorded.

resultsKnockdown ranged from 91.19% to 99.47% for wild-caught sand flies and from 91.70% to 98.89% for their F1 progeny. At 24 h post-exposure, mortality ranged from 89.34% to 98.93% for wild-caught sand flies and from 90.16% to 98.33% for F1 progeny.

conclusionsThe results of this study showed that P. argentipes is potentially developing resistance, signalling the need for continuous monitoring and vigilance to sustain the validation of elimination once achieved.

Indexed as

Biological AssayInsecticide ResistanceInsecticidesLeishmaniasis, VisceralPhlebotomusPyrethrinsAnimalsFemaleIndiaInsect VectorsMalecypermethrinInsecticidesPyrethrinsCDC bottle bioassayDiagnostic dose and exposure timeInsecticide susceptibilityPhlebotomus argentipes

Identifiers

PMID39639391
PMCPMC11622483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.